Page 10 of 14 – SEC Filing
|
CUSIP No. 57165B106 | 13G | Page 10 of 14 Pages |
Item 1. | |||||
| (a) Name of Issuer: | Marrone Bio Innovations, Inc. | ||||
| (b) Address of Issuer’s Principal Executive Offices: | 1540 Davis, | ||||
| Item 2. | |||||
| (a) Name of Person Filing: | This Schedule 13G (the “Schedule”) is being filed with respect to shares of Common Stock (as defined below) of Marrone Bio Innovations, Inc. (the “Issuer”) which are beneficially owned by Ardsley Advisory Partners (the “Advisor”), Ardsley Partners I (the “General Partner”), Phillip J. Hempleman (“Hempleman”), Ardsley Partners Fund II, L.P. (the “Fund II”), Ardsley Partners Institutional Fund, L.P. (the “Institutional Fund”), Ardsley Partners Advanced Healthcare Fund, L.P. (the “Healthcare Fund”), Ardsley Partners Renewable Energy Fund (the “Renewable Energy Fund”) and Ardsley Duckdive Fund, L.P. (the “Duckdive Fund”) (together, the “Reporting Persons”). See Item 4 below. | ||||
| (b) Address of Principal Business Office or, if none, Residence: | 262 Stamford, | ||||
| (c) Citizenship: | The Fund II, the Institutional Fund, the Advanced Healthcare Fund, the Renewable Energy Fund and the Duckdive Fund are Delaware limited partnerships. The Advisor and the General Partner are New York general partnerships. Hempleman is a United States Citizen. | ||||
| (d) Title of Class of Securities: | Common Stock | ||||
| (e) CUSIP Number: | 57165B106 | ||||
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
| (a) | o | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
| (b) | o | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | o | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
| (d) | o | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). |
| (e) | x | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) | o | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
| (g) | o | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
| (h) | o | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) | o | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
| (j) | o | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
Follow Marrone Bio Innovations Inc (NASDAQ:MBII)
Follow Marrone Bio Innovations Inc (NASDAQ:MBII)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
